Trial intelligence / Profile preview

Eutropin vs Genotropin in Infants/Toddlers with Prader-Willi Syndrome

NCT02204163Phase 3Completed

Sponsor
LG Chem
Start
Jun 2014
Primary completion
Dec 2017
Modality
Device-based Delivery
Countries
1
01

Overview

A Phase 3 trial of Eutropin in Prader-Willi syndrome (PWS), sponsored by LG Chem. Started Jun 2014; status: completed.

02

Drugs

Eutropin
03

Conditions

Prader-Willi syndrome (PWS)

Beyond the preview

Go deeper on NCT02204163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02204163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call